和谐生物科学控股有限公司
US ˙ NasdaqGM ˙ US4131971040

介绍

本页面提供了有关 Andreas Wicki 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言，基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是，他们必须通过Form 4向美国证券交易委员会（SEC）报告所有交易。尽管存在这些限制，学术研究表明，整体而言，内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易，排除了作为10b5-1交易计划的一部分的交易。然后，对每笔交易在3、6和12个月的表现进行平均，以生成该笔交易最终的表现指标。然后，将所有交易的表现指标进行平均，计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A"，则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易，或者他们进行的交易距离现在时间太近，无法计算出可靠的表现指标。

更新频率：每日

查看收益最高的的内幕交易者列表。

查看排名最高的内部人士。
报告内部持仓的公司

美国证券交易委员会（SEC）文件显示Andreas Wicki已报告在以下公司拥有持仓或进行了交易：

证券 职位 最新报告的持仓
US:HRMY / Harmony Biosciences Holdings, Inc. Director 2,147,943
US:PCRX / Pacira BioSciences, Inc. Director 451,324
Director 0
如何解读这些图表

以下图表显示了在Andreas Wicki进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如，如果一笔内部人士交易是在2019年1月1日进行的，该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元，则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%，而从10美元跌至5美元的价格变化将为-50%。

最终，我们将评估内部人士的交易与股价的超额回报（正向或负向）之间的相关性，以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为，我们预期看到（a）买入后的正回报，或者（b）卖出后的负回报。对于情况（a），买入图表将显示一系列向上倾斜的曲线，表示每次买入后都有正回报。对于情况（b），卖出图表将显示一系列向下倾斜的曲线，表示每次卖出后都有负回报。

然而，仅凭这一点还不足以得出结论。例如，如果公司的股价在多年内呈现非周期性上升，我们会预期所有买入后的图表都呈现向上倾斜。同样地，多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下，“买入”图表显示正向信号，而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易，以获得财务优势。

HRMY / Harmony Biosciences Holdings, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 HRMY / Harmony Biosciences Holdings, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

HRMY / Harmony Biosciences Holdings, Inc. Insider Trades
HRMY / Harmony Biosciences Holdings, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 HRMY / Harmony Biosciences Holdings, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2022-12-14 HRMY Wicki Andreas 130 60.0000 130 60.0000 7,800 317 19.2000 -5,304 -68.00
2022-12-13 HRMY Wicki Andreas 6,320 60.1300 6,320 60.1300 380,022
2022-12-12 HRMY Wicki Andreas 22,391 60.3600 22,391 60.3600 1,351,521
2022-12-05 HRMY Wicki Andreas 77,853 61.2300 77,853 61.2300 4,766,939
2022-11-15 HRMY Wicki Andreas 10,961 60.1000 10,961 60.1000 658,756
2022-11-14 HRMY Wicki Andreas 40,317 59.1000 40,317 59.1000 2,382,735
2022-11-10 HRMY Wicki Andreas 95,242 58.8000 95,242 58.8000 5,600,230
2022-11-09 HRMY Wicki Andreas 15,301 58.0500 15,301 58.0500 888,223
2022-11-08 HRMY Wicki Andreas 18,865 60.0100 18,865 60.0100 1,132,089
2022-11-04 HRMY Wicki Andreas 157,950 58.8100 157,950 58.8100 9,289,040
2022-11-03 HRMY Wicki Andreas 254,141 59.4400 254,141 59.4400 15,106,141
2022-11-02 HRMY Wicki Andreas 164,676 58.8100 164,676 58.8100 9,684,596
2022-08-10 HRMY Wicki Andreas 71,447 52.6100 71,447 52.6100 3,758,827
2022-08-09 HRMY Wicki Andreas 20,745 53.6700 20,745 53.6700 1,113,384
2022-08-08 HRMY Wicki Andreas 486,360 53.9400 486,360 53.9400 26,234,258
2022-08-05 HRMY Wicki Andreas 29,482 52.5700 29,482 52.5700 1,549,869
2022-08-04 HRMY Wicki Andreas 12,640 52.6700 12,640 52.6700 665,749
2022-08-03 HRMY Wicki Andreas 30,464 52.9000 30,464 52.9000 1,611,546
2022-03-11 HRMY Wicki Andreas 70,370 44.1400 70,370 44.1400 3,106,132
2022-03-10 HRMY Wicki Andreas 75,217 45.8000 75,217 45.8000 3,444,939
2022-03-09 HRMY Wicki Andreas 140,000 45.4900 140,000 45.4900 6,368,600
2022-03-03 HRMY Wicki Andreas 175,000 41.0100 175,000 41.0100 7,176,750
2022-03-02 HRMY Wicki Andreas 328,927 40.5200 328,927 40.5200 13,328,122
2022-03-01 HRMY Wicki Andreas 92,501 40.2400 92,501 40.2400 3,722,240
2021-12-10 HRMY Wicki Andreas 2,585 40.0800 2,585 40.0800 103,607
2021-12-08 HRMY Wicki Andreas 24,683 40.0900 24,683 40.0900 989,541
2021-11-17 HRMY Wicki Andreas 1,417 41.2500 1,417 41.2500 58,451
2021-11-16 HRMY Wicki Andreas 32,251 41.0900 32,251 41.0900 1,325,194
2021-11-15 HRMY Wicki Andreas 35,600 42.0800 35,600 42.0800 1,498,048

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

HRMY / Harmony Biosciences Holdings, Inc. Insider Trades
PCRX / Pacira BioSciences, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 HRMY / Harmony Biosciences Holdings, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

PCRX / Pacira BioSciences, Inc. Insider Trades
PCRX / Pacira BioSciences, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 HRMY / Harmony Biosciences Holdings, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2021-03-15 PCRX Wicki Andreas 10,601 73.6800 10,601 73.6800 781,082 207 47.9700 -272,551 -34.89
2021-03-12 PCRX Wicki Andreas 58,754 73.1000 58,754 73.1000 4,294,917
2021-03-11 PCRX Wicki Andreas 60,574 72.7000 60,574 72.7000 4,403,730
2021-03-10 PCRX Wicki Andreas 76,480 71.7800 76,480 71.7800 5,489,734
2021-03-09 PCRX Wicki Andreas 35,137 70.9000 35,137 70.9000 2,491,213
2020-09-09 PCRX Wicki Andreas 2,216 62.0200 2,216 62.0200 137,436
2020-08-13 PCRX Wicki Andreas 34,904 61.4700 34,904 61.4700 2,145,549
2020-08-12 PCRX Wicki Andreas 113,500 60.8200 113,500 60.8200 6,903,070
2020-08-11 PCRX Wicki Andreas 60,621 60.8700 60,621 60.8700 3,690,000
2020-08-11 PCRX Wicki Andreas 46,151 61.9000 46,151 61.9000 2,856,747
2018-12-13 PCRX Wicki Andreas 8,720 46.1803 8,720 46.1803 402,692
2018-12-12 PCRX Wicki Andreas 5,807 47.8394 5,807 47.8394 277,803
2018-11-19 PCRX Wicki Andreas 990 47.0761 990 47.0761 46,605
2018-11-16 PCRX Wicki Andreas 22,100 46.7892 22,100 46.7892 1,034,041
2018-11-16 PCRX Wicki Andreas 3,500 47.0669 3,500 47.0669 164,734
2018-11-15 PCRX Wicki Andreas 26,089 47.6318 26,089 47.6318 1,242,666
2018-11-15 PCRX Wicki Andreas 18,809 47.6445 18,809 47.6445 896,145
2018-11-12 PCRX Wicki Andreas 5,478 49.8321 5,478 49.8321 272,980
2018-11-09 PCRX Wicki Andreas 906 50.2298 906 50.2298 45,508
2018-11-08 PCRX Wicki Andreas 57,339 51.1272 57,339 51.1272 2,931,583
2014-08-29 PCRX Wicki Andreas 10,481 108.1538 10,481 108.1538 1,133,560
2014-08-28 PCRX Wicki Andreas 11,013 108.0629 11,013 108.0629 1,190,097
2014-08-27 PCRX Wicki Andreas 1,606 108.0539 1,606 108.0539 173,535
2014-08-26 PCRX Wicki Andreas 24,207 108.1099 24,207 108.1099 2,617,016
2014-08-25 PCRX Wicki Andreas 30,000 108.0661 30,000 108.0661 3,241,983
2014-08-11 PCRX Wicki Andreas 30,114 101.1959 30,114 101.1959 3,047,413
2014-08-11 PCRX Wicki Andreas 37,786 101.8232 37,786 101.8232 3,847,491
2014-08-08 PCRX Wicki Andreas 82,100 101.0001 82,100 101.0001 8,292,108
2014-06-03 PCRX Wicki Andreas 57,400 80.7179 57,400 80.7179 4,633,207
2014-03-06 PCRX Wicki Andreas 2,200 80.1111 2,200 80.1111 176,244
2014-03-05 PCRX Wicki Andreas 22,687 80.1627 22,687 80.1627 1,818,651
2013-09-11 PCRX Wicki Andreas 2,686 37.2500 2,686 37.2500 100,054
2013-09-11 PCRX Wicki Andreas 15,097 37.2500 15,097 37.2500 562,363
2013-06-12 PCRX Wicki Andreas 4,409 30.0000 4,409 30.0000 132,270
2013-06-11 PCRX Wicki Andreas 9,000 30.0000 9,000 30.0000 270,000
2013-06-10 PCRX Wicki Andreas 2,500 30.0000 2,500 30.0000 75,000
2013-06-05 PCRX Wicki Andreas 2,500 30.0000 2,500 30.0000 75,000
2013-06-04 PCRX Wicki Andreas 13,000 30.3100 13,000 30.3100 394,030
2013-06-03 PCRX Wicki Andreas 1,900 30.0000 1,900 30.0000 57,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

PCRX / Pacira BioSciences, Inc. Insider Trades
内幕交易历史

该表格显示了由 Andreas Wicki 进行的所有内幕交易的完整列表，这些交易已向美国证券交易委员会（SEC）披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化		 每股
股价		 交易
金额		 剩余
金额
2022-12-14 2022-12-14 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -130 2,147,943 -0.01 60.00 -7,800 128,876,580
2022-12-14 2022-12-13 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -6,320 2,148,073 -0.29 60.13 -380,022 129,163,629
2022-12-14 2022-12-12 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -22,391 2,154,393 -1.03 60.36 -1,351,521 130,039,161
2022-12-07 2022-12-05 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -77,853 2,176,784 -3.45 61.23 -4,766,939 133,284,484
2022-11-16 2022-11-15 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -10,961 2,254,637 -0.48 60.10 -658,756 135,503,684
2022-11-16 2022-11-14 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -40,317 2,265,598 -1.75 59.10 -2,382,735 133,896,842
2022-11-10 2022-11-10 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -95,242 2,305,915 -3.97 58.80 -5,600,230 135,587,802
2022-11-10 2022-11-09 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -15,301 2,401,157 -0.63 58.05 -888,223 139,387,164
2022-11-10 2022-11-08 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -18,865 2,416,458 -0.77 60.01 -1,132,089 145,011,645
2022-11-04 2022-11-04 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -157,950 2,435,323 -6.09 58.81 -9,289,040 143,221,346
2022-11-04 2022-11-03 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -254,141 2,593,273 -8.93 59.44 -15,106,141 154,144,147
2022-11-04 2022-11-02 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -164,676 2,847,414 -5.47 58.81 -9,684,596 167,456,417
2022-08-10 2022-08-10 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -71,447 3,012,090 -2.32 52.61 -3,758,827 158,466,055
2022-08-10 2022-08-09 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -20,745 3,083,537 -0.67 53.67 -1,113,384 165,493,431
2022-08-10 2022-08-08 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -486,360 3,104,282 -13.55 53.94 -26,234,258 167,444,971
2022-08-05 2022-08-05 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -29,482 3,590,642 -0.81 52.57 -1,549,869 188,760,050
2022-08-05 2022-08-04 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -12,640 3,620,124 -0.35 52.67 -665,749 190,671,931
2022-08-05 2022-08-03 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -30,464 3,632,764 -0.83 52.90 -1,611,546 192,173,216
2022-03-11 2022-03-11 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -70,370 3,663,228 -1.88 44.14 -3,106,132 161,694,884
2022-03-11 2022-03-10 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -75,217 3,733,598 -1.97 45.80 -3,444,939 170,998,788
2022-03-11 2022-03-09 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -140,000 3,808,815 -3.55 45.49 -6,368,600 173,262,994
2022-03-04 2022-03-03 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -175,000 3,948,815 -4.24 41.01 -7,176,750 161,940,903
2022-03-04 2022-03-02 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -328,927 4,123,815 -7.39 40.52 -13,328,122 167,096,984
2022-03-04 2022-03-01 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -92,501 4,452,742 -2.04 40.24 -3,722,240 179,178,338
2021-12-10 2021-12-10 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -2,585 4,545,243 -0.06 40.08 -103,607 182,173,339
2021-12-10 2021-12-08 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -24,683 4,547,828 -0.54 40.09 -989,541 182,322,425
2021-11-17 2021-11-17 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -1,417 4,572,511 -0.03 41.25 -58,451 188,616,079
2021-11-17 2021-11-16 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -32,251 4,573,928 -0.70 41.09 -1,325,194 187,942,702
2021-11-17 2021-11-15 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -35,600 4,609,179 -0.77 42.08 -1,498,048 193,954,252
2021-03-16 2021-03-15 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -10,601 451,324 -2.29 73.68 -781,082 33,253,552
2021-03-16 2021-03-12 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -58,754 461,925 -11.28 73.10 -4,294,917 33,766,718
2021-03-15 2021-03-13 4 VIE Viela Bio, Inc.
Common Stock 		D - Sale to Issuer -1,750,000 0 -100.00 53.00 -92,750,000
2021-03-11 2021-03-11 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -60,574 520,679 -10.42 72.70 -4,403,730 37,853,363
2021-03-11 2021-03-10 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -76,480 581,253 -11.63 71.78 -5,489,734 41,722,340
2021-03-11 2021-03-09 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -35,137 657,733 -5.07 70.90 -2,491,213 46,633,270
2020-09-11 2020-09-09 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -2,216 692,970 -0.32 62.02 -137,436 42,977,999
2020-08-13 2020-08-13 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -34,904 695,186 -4.78 61.47 -2,145,549 42,733,083
2020-08-13 2020-08-12 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -113,500 730,090 -13.45 60.82 -6,903,070 44,404,074
2020-08-13 2020-08-11 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -46,151 843,590 -5.19 61.90 -2,856,747 52,218,221
2020-08-13 2020-08-11 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -60,621 889,741 -6.38 60.87 -3,690,000 54,158,535
2019-10-09 2019-10-07 4 VIE Viela Bio, Inc.
Series B Preferred Stock 		C - Conversion -1,250,000 0 -100.00
2019-10-09 2019-10-07 4 VIE Viela Bio, Inc.
Common Stock 		P - Purchase 500,000 1,750,000 40.00 19.00 9,500,000 33,250,000
2019-10-09 2019-10-07 4 VIE Viela Bio, Inc.
Common Stock 		C - Conversion 1,250,000 1,250,000
2018-12-14 2018-12-13 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -8,720 950,362 -0.91 46.18 -402,692 43,888,002
2018-12-14 2018-12-12 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -5,807 959,082 -0.60 47.84 -277,803 45,881,907
2018-11-21 2018-11-19 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -990 964,889 -0.10 47.08 -46,605 45,423,211
2018-11-19 2018-11-16 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -3,500 965,879 -0.36 47.07 -164,734 45,460,930
2018-11-19 2018-11-16 4 PCRX Pacira Pharmaceuticals, Inc.
Common stock 		S - Sale -22,100 969,379 -2.23 46.79 -1,034,041 45,356,468
2018-11-19 2018-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -18,809 991,479 -1.86 47.64 -896,145 47,238,521
2018-11-19 2018-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -26,089 1,010,288 -2.52 47.63 -1,242,666 48,121,836
2018-11-14 2018-11-12 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -5,478 1,036,377 -0.53 49.83 -272,980 51,644,842
2018-11-13 2018-11-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -906 1,041,855 -0.09 50.23 -45,508 52,332,168
2018-11-13 2018-11-08 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -57,339 1,042,761 -5.21 51.13 -2,931,583 53,313,450
2014-09-02 2014-08-29 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -10,481 1,100,100 -0.94 108.15 -1,133,560 118,979,995
2014-09-02 2014-08-28 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -11,013 1,110,581 -0.98 108.06 -1,190,097 120,012,604
2014-08-27 2014-08-27 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -1,606 1,121,594 -0.14 108.05 -173,535 121,192,606
2014-08-27 2014-08-26 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -24,207 1,123,200 -2.11 108.11 -2,617,016 121,429,040
2014-08-27 2014-08-25 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -30,000 1,147,407 -2.55 108.07 -3,241,983 123,995,800
2014-08-12 2014-08-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -37,786 1,177,407 -3.11 101.82 -3,847,491 119,887,348
2014-08-12 2014-08-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -30,114 1,215,193 -2.42 101.20 -3,047,413 122,972,549
2014-08-12 2014-08-08 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -82,100 1,245,307 -6.18 101.00 -8,292,108 125,776,132
2014-06-11 2014-06-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,289 1,327,407 -0.69 86.43 -802,882 114,732,566
2014-06-11 2014-06-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -33,653 1,336,696 -2.46 85.81 -2,887,680 114,698,542
2014-06-11 2014-06-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -25,058 1,370,349 -1.80 84.55 -2,118,624 115,861,364
2014-06-06 2014-06-06 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -40,200 1,395,407 -2.80 82.71 -3,324,753 115,407,555
2014-06-06 2014-06-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -23,200 1,435,607 -1.59 82.53 -1,914,668 118,478,923
2014-06-06 2014-06-04 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,500 1,458,807 -0.31 82.40 -370,809 120,208,469
2014-06-03 2014-06-03 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -57,400 1,463,307 -3.77 80.72 -4,633,207 118,115,068
2014-06-03 2014-06-02 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -10,600 1,520,707 -0.69 80.52 -853,498 122,445,351
2014-05-28 2014-05-27 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -64,400 1,531,307 -4.04 77.93 -5,018,750 119,336,133
2014-05-22 2014-05-21 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,600 1,595,707 -0.23 77.80 -280,086 124,148,717
2014-05-12 2014-05-08 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -23,220 1,599,307 -1.43 75.76 -1,759,215 121,168,136
2014-05-07 2014-05-07 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -600 1,622,527 -0.04 75.64 -45,386 122,731,999
2014-05-07 2014-05-06 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -44,180 1,623,127 -2.65 75.78 -3,348,062 123,004,297
2014-03-06 2014-03-06 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,200 1,667,307 -0.13 80.11 -176,244 133,569,798
2014-03-06 2014-03-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -22,687 1,669,507 -1.34 80.16 -1,818,651 133,832,189
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Warrant (right to buy) 		X - Other -41,841 0 -100.00
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Warrant (right to buy) 		X - Other -37,192 0 -100.00
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -15,097 1,692,194 -0.88 37.25 -562,363 63,034,226
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		X - Other 41,841 1,707,291 2.51 13.44 562,343 22,945,991
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,686 1,665,450 -0.16 37.25 -100,054 62,038,012
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		X - Other 37,192 1,668,136 2.28 2.69 100,046 4,487,286
2013-07-23 2013-07-22 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -19,938 1,630,944 -1.21 35.28 -703,508 57,547,533
2013-07-23 2013-07-19 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -56,020 1,650,882 -3.28 34.98 -1,959,524 57,746,201
2013-07-19 2013-07-18 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,042 1,706,902 -0.24 34.80 -140,662 59,400,190
2013-07-19 2013-07-17 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -21,518 1,710,944 -1.24 33.20 -714,398 56,803,341
2013-07-17 2013-07-16 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -350 1,732,462 -0.02 33.20 -11,620 57,517,738
2013-07-17 2013-07-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -48,132 1,732,812 -2.70 33.28 -1,601,833 57,667,983
2013-07-15 2013-07-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -80,000 1,780,944 -4.30 31.48 -2,518,416 56,064,473
2013-07-09 2013-07-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -44,021 1,860,944 -2.31 30.80 -1,355,961 57,321,914
2013-07-03 2013-07-03 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -50,000 1,904,965 -2.56 30.67 -1,533,300 58,417,657
2013-07-03 2013-07-02 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -60,597 1,954,965 -3.01 29.85 -1,808,820 58,355,705
2013-07-03 2013-07-01 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,851 2,015,562 -0.19 29.85 -114,952 60,164,526
2013-06-21 2013-06-19 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -35,407 2,019,413 -1.72 29.90 -1,058,726 60,383,680
2013-06-19 2013-06-17 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -50,145 2,054,820 -2.38 29.86 -1,497,224 61,352,610
2013-06-14 2013-06-12 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -4,409 2,104,965 -0.21 30.00 -132,270 63,148,950
2013-06-12 2013-06-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -9,000 2,109,374 -0.42 30.00 -270,000 63,281,220
2013-06-12 2013-06-10 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,500 2,118,374 -0.12 30.00 -75,000 63,551,220
2013-06-06 2013-06-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,500 2,120,874 -0.12 30.00 -75,000 63,626,220
2013-06-06 2013-06-04 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -13,000 2,123,374 -0.61 30.31 -394,030 64,359,466
2013-06-05 2013-06-03 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -1,900 2,136,374 -0.09 30.00 -57,000 64,091,220
2013-05-31 2013-05-31 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,033 2,138,274 -0.14 30.00 -90,990 64,148,220
2013-05-31 2013-05-30 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,500 2,141,307 -0.12 30.00 -75,000 64,239,210
2013-05-24 2013-05-22 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -18,471 2,143,807 -0.85 30.00 -554,130 64,314,210
2013-05-22 2013-05-20 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -14,374 2,162,278 -0.66 30.00 -431,220 64,868,340
2013-04-25 2013-04-24 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -401 2,176,652 -0.02 30.04 -12,045 65,380,967
2013-04-25 2013-04-23 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -15,646 2,177,053 -0.71 30.00 -469,380 65,311,590
2013-04-17 2013-04-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,400 2,192,699 -0.29 30.00 -192,020 65,787,987
2013-04-15 2013-04-12 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -34,294 2,199,099 -1.54 30.00 -1,028,820 65,972,970
2013-04-15 2013-04-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -600 2,233,393 -0.03 30.00 -18,000 67,001,790
2013-03-25 2013-03-25 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -165,541 2,233,993 -6.90 28.28 -4,680,738 63,167,046
2013-03-25 2013-03-22 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -113,928 2,399,534 -4.53 27.52 -3,135,595 66,041,414
2013-03-25 2013-03-21 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -11,431 2,513,462 -0.45 27.50 -314,352 69,120,205
2013-03-21 2013-03-19 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,100 2,524,893 -0.36 27.86 -253,501 70,336,449
2013-03-21 2013-03-18 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -400,000 2,533,993 -13.63 28.19 -11,277,480 71,442,638
2013-03-21 2013-03-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -500,000 2,933,993 -14.56 27.86 -13,930,000 81,741,045
2011-02-02 3 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		92,980
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券（例如期权）
V
内部人士通过Form 4自愿报告的一笔交易
J
其他（附有交易描述的脚注）